Share-based Payment Arrangement, Expense of Cadrenal Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cadrenal Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Cadrenal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $473,384, a 58% increase year-over-year.
  • Cadrenal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,378,001, a 213% increase year-over-year.
  • Cadrenal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,419,039, a 100% increase from 2023.
  • Cadrenal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $710,381, a 23% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Cadrenal Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,378,001 $473,384 +$173,404 +58% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $2,204,597 $592,644 +$399,524 +207% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,805,073 $548,765 +$386,034 +237% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,419,039 $763,208 +$660,096 +640% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $758,943 $299,980 +$146,908 +96% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $612,035 $193,120 +$25,319 +15% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $586,716 $162,731 -$123,665 -43% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $710,381 $103,112 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $153,072 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $167,801 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $286,396 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1

Cadrenal Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,419,039 +$708,658 +100% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $710,381 -$217,668 -23% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $928,049 25 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.